+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Consumer Healthcare Market by Product, Distribution - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 195 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 5336904
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Consumer Healthcare Market grew from USD 333.03 billion in 2023 to USD 356.94 billion in 2024. It is expected to continue growing at a CAGR of 7.38%, reaching USD 548.31 billion by 2030.

The consumer healthcare market encompasses a wide array of products designed to support individuals' health and wellness without the need for a prescription. These include over-the-counter drugs, dietary supplements, vitamins, functional foods, and personal care products. The necessity for consumer healthcare is driven by a growing awareness and proactive approach toward personal health management, compounded by an increasing prevalence of lifestyle-related illnesses. This market finds significant application in preventative health care and in meeting the needs of self-medication, convenience, and affordability, catering primarily to end-users such as individuals, sports and fitness enthusiasts, and health-conscious consumers.

Key factors influencing growth in this market include rising consumer health awareness, increased disposable incomes, and the expansion of e-commerce enabling easy access to these products. Moreover, the global COVID-19 pandemic has accelerated the demand for health and wellness products. Market insights illuminate potential opportunities such as the growing demand for personalized healthcare solutions, advancements in digital health technologies, and expansion into emerging markets with untapped potential. Companies are recommended to invest in R&D for innovative product formulations and leverage data analytics for personalized marketing strategies to seize these opportunities.

However, the market is not without its challenges. Regulatory hurdles and stringent compliance standards can pose significant limitations. Moreover, the high competition and the availability of counterfeit products are critical challenges impacting market growth. Innovation should focus on integrating AI and machine learning for consumer behavior analytics, developing eco-friendly packaging, and enhancing the nutritional profiles of products. The nature of the consumer healthcare market is dynamic, characterized by rapid innovation and a strong focus on consumer-centric approaches. To maintain competitiveness, businesses must be agile, prioritize sustainability, and continuously adapt to shifting consumer preferences and regulatory landscapes. Exploring collaborations and partnerships can also be a viable strategy to drive growth and innovation in this sector.

Understanding Market Dynamics in the Consumer Healthcare Market

The Consumer Healthcare Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Rising geriatric population and inclination of consumers towards self-medication products
    • Government support to offer affordable and improved access to healthcare
    • Growing adoption of private labels consumer healthcare products
  • Market Restraints
    • Availability of counterfeit products that lack active pharmaceutical ingredients
  • Market Opportunities
    • Increasing approval rate of wellness and preventive medicines
    • Rapid growth of online pharmacies and improved availability through online platforms
  • Market Challenges
    • Concerns associated with abuse and misuse of consumer healthcare products

Exploring Porter’s Five Forces for the Consumer Healthcare Market

Porter’s Five Forces framework further strengthens the insights of the Consumer Healthcare Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Consumer Healthcare Market

External macro-environmental factors deeply influence the performance of the Consumer Healthcare Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Consumer Healthcare Market

The Consumer Healthcare Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Consumer Healthcare Market

The Consumer Healthcare Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Consumer Healthcare Market

The Consumer Healthcare Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Consumer Healthcare Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories Inc., Alembic Pharmaceuticals Ltd., Alkem Laboratories Limited, AMCO Proteins, American Health Inc., Amway Corporation by Alticor corporation, Axtria Inc., BASF SE, Bayer AG, Bionova Lifesciences by Pragati Biocare Pvt. Ltd., Boehringer Ingelheim International GmbH, Cipla, Inc., Dr. Reddy's Laboratories, Eli Lilly and Company, Endo Pharmaceuticals PLC by DuPont de Nemours, Inc., Gemini Pharmaceuticals Inc., Glanbia PLC, GlaxoSmithKline PLC, Glenmark Pharmaceuticals Ltd., Henin Lukinz Pvt. Ltd., Herbalife Ltd., Hetero Drugs Ltd., Himalaya Wellness Company, Iovate Health Sciences International Inc., Ipsen S.A., Johnson & Johnson Services, Inc., Koninklijke DSM N.V., Lonza Group Ltd., Lupin Limited, Mankind Pharma, MusclePharm Corporation, Mylan Pharmaceuticals Pvt. Ltd. by Viatris, Nature's Bounty, Inc. by Nestlé S.A., Novartis AG, Omega Protein Corporation, Pfizer Inc., Piramal Group, Procter & Gamble Company, PureTek Corporation, QuestNutrition, Reckitt Benckiser Group PLC, Sanofi S.A., Sun Pharmaceutical Industries Limited, Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., Ventus Pharmaceuticals Private Limited, and Zoic Biotech Private Limited.

Market Segmentation & Coverage

This research report categorizes the Consumer Healthcare Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Product
    • Dietary Supplements
    • OTC Pharmaceuticals
  • Distribution
    • Departmental Stores
    • Independent Retailers
    • Pharmacies or Drugstores
    • Specialist Retailers
    • Supermarkets or Hypermarkets
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising geriatric population and inclination of consumers towards self-medication products
5.1.1.2. Government support to offer affordable and improved access to healthcare
5.1.1.3. Growing adoption of private labels consumer healthcare products
5.1.2. Restraints
5.1.2.1. Availability of counterfeit products that lack active pharmaceutical ingredients
5.1.3. Opportunities
5.1.3.1. Increasing approval rate of wellness and preventive medicines
5.1.3.2. Rapid growth of online pharmacies and improved availability through online platforms
5.1.4. Challenges
5.1.4.1. Concerns associated with abuse and misuse of consumer healthcare products
5.2. Market Segmentation Analysis
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Consumer Healthcare Market, by Product
6.1. Introduction
6.2. Dietary Supplements
6.3. OTC Pharmaceuticals
7. Consumer Healthcare Market, by Distribution
7.1. Introduction
7.2. Departmental Stores
7.3. Independent Retailers
7.4. Pharmacies or Drugstores
7.5. Specialist Retailers
7.6. Supermarkets or Hypermarkets
8. Americas Consumer Healthcare Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States
9. Asia-Pacific Consumer Healthcare Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam
10. Europe, Middle East & Africa Consumer Healthcare Market
10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom
11. Competitive Landscape
11.1. Market Share Analysis, 2023
11.2. FPNV Positioning Matrix, 2023
11.3. Competitive Scenario Analysis
11.3.1. SPE Capital acquires majority stake in Vital, the leading nutritional supplements company in Tunisia
11.3.2. Nutrilitius expands portfolio with launch of new range of nutraceuticals, Unleashing the Power of Food Science & Technology
11.3.3. LBB Specialties and DSM announce partnership for North America Dietary Supplements Distribution
11.3.4. Cosmos Health to Launch Sky Premium Life Nutritional Supplement Products in Germany and Austria via Amazon and Ebay
11.3.5. health supplements: Tata Consumer enters health supplements segment, launches plant protein powder
11.3.6. Cipla Health to buy nutritional supplement brand Endura Mass
11.3.7. Orkla Health acquires Healthspan
11.3.8. Amway India launches nutrition supplements in gummies and jelly strips
11.3.9. Wellbeing Nutrition raises $2.2 million led by Fireside Ventures
11.3.10. Bayer launches Consumer Health division in India
11.4. Strategy Analysis & Recommendation
List of Figures
FIGURE 1. CONSUMER HEALTHCARE MARKET RESEARCH PROCESS
FIGURE 2. CONSUMER HEALTHCARE MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL CONSUMER HEALTHCARE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL CONSUMER HEALTHCARE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL CONSUMER HEALTHCARE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 7. GLOBAL CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2023 VS 2030 (%)
FIGURE 9. GLOBAL CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. AMERICAS CONSUMER HEALTHCARE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 11. AMERICAS CONSUMER HEALTHCARE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. UNITED STATES CONSUMER HEALTHCARE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 13. UNITED STATES CONSUMER HEALTHCARE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. ASIA-PACIFIC CONSUMER HEALTHCARE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 15. ASIA-PACIFIC CONSUMER HEALTHCARE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. EUROPE, MIDDLE EAST & AFRICA CONSUMER HEALTHCARE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA CONSUMER HEALTHCARE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. CONSUMER HEALTHCARE MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 19. CONSUMER HEALTHCARE MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. CONSUMER HEALTHCARE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL CONSUMER HEALTHCARE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL CONSUMER HEALTHCARE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL CONSUMER HEALTHCARE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. CONSUMER HEALTHCARE MARKET DYNAMICS
TABLE 7. GLOBAL CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL CONSUMER HEALTHCARE MARKET SIZE, BY DIETARY SUPPLEMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL CONSUMER HEALTHCARE MARKET SIZE, BY OTC PHARMACEUTICALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL CONSUMER HEALTHCARE MARKET SIZE, BY DEPARTMENTAL STORES, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL CONSUMER HEALTHCARE MARKET SIZE, BY INDEPENDENT RETAILERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL CONSUMER HEALTHCARE MARKET SIZE, BY PHARMACIES OR DRUGSTORES, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL CONSUMER HEALTHCARE MARKET SIZE, BY SPECIALIST RETAILERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL CONSUMER HEALTHCARE MARKET SIZE, BY SUPERMARKETS OR HYPERMARKETS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. AMERICAS CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 17. AMERICAS CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 18. AMERICAS CONSUMER HEALTHCARE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 19. ARGENTINA CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 20. ARGENTINA CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 21. BRAZIL CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 22. BRAZIL CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 23. CANADA CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 24. CANADA CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 25. MEXICO CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 26. MEXICO CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 27. UNITED STATES CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 28. UNITED STATES CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 29. UNITED STATES CONSUMER HEALTHCARE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 30. ASIA-PACIFIC CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 31. ASIA-PACIFIC CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 32. ASIA-PACIFIC CONSUMER HEALTHCARE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 33. AUSTRALIA CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 34. AUSTRALIA CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 35. CHINA CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 36. CHINA CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 37. INDIA CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 38. INDIA CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 39. INDONESIA CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 40. INDONESIA CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 41. JAPAN CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 42. JAPAN CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 43. MALAYSIA CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 44. MALAYSIA CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 45. PHILIPPINES CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 46. PHILIPPINES CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 47. SINGAPORE CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 48. SINGAPORE CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 49. SOUTH KOREA CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 50. SOUTH KOREA CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 51. TAIWAN CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 52. TAIWAN CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 53. THAILAND CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 54. THAILAND CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 55. VIETNAM CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 56. VIETNAM CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 57. EUROPE, MIDDLE EAST & AFRICA CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 58. EUROPE, MIDDLE EAST & AFRICA CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 59. EUROPE, MIDDLE EAST & AFRICA CONSUMER HEALTHCARE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 60. DENMARK CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 61. DENMARK CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 62. EGYPT CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 63. EGYPT CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 64. FINLAND CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 65. FINLAND CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 66. FRANCE CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 67. FRANCE CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 68. GERMANY CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 69. GERMANY CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 70. ISRAEL CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 71. ISRAEL CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 72. ITALY CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 73. ITALY CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 74. NETHERLANDS CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 75. NETHERLANDS CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 76. NIGERIA CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 77. NIGERIA CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 78. NORWAY CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 79. NORWAY CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 80. POLAND CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 81. POLAND CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 82. QATAR CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 83. QATAR CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 84. RUSSIA CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 85. RUSSIA CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 86. SAUDI ARABIA CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 87. SAUDI ARABIA CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 88. SOUTH AFRICA CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 89. SOUTH AFRICA CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 90. SPAIN CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 91. SPAIN CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 92. SWEDEN CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 93. SWEDEN CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 94. SWITZERLAND CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 95. SWITZERLAND CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 96. TURKEY CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 97. TURKEY CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 98. UNITED ARAB EMIRATES CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 99. UNITED ARAB EMIRATES CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 100. UNITED KINGDOM CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 101. UNITED KINGDOM CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 102. CONSUMER HEALTHCARE MARKET SHARE, BY KEY PLAYER, 2023
TABLE 103. CONSUMER HEALTHCARE MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the Consumer Healthcare Market, which are profiled in this report, include:
  • Abbott Laboratories Inc.
  • Alembic Pharmaceuticals Ltd.
  • Alkem Laboratories Limited
  • AMCO Proteins
  • American Health Inc.
  • Amway Corporation by Alticor corporation
  • Axtria Inc.
  • BASF SE
  • Bayer AG
  • Bionova Lifesciences by Pragati Biocare Pvt. Ltd.
  • Boehringer Ingelheim International GmbH
  • Cipla, Inc.
  • Dr. Reddy's Laboratories
  • Eli Lilly and Company
  • Endo Pharmaceuticals PLC by DuPont de Nemours, Inc.
  • Gemini Pharmaceuticals Inc.
  • Glanbia PLC
  • GlaxoSmithKline PLC
  • Glenmark Pharmaceuticals Ltd.
  • Henin Lukinz Pvt. Ltd.
  • Herbalife Ltd.
  • Hetero Drugs Ltd.
  • Himalaya Wellness Company
  • Iovate Health Sciences International Inc.
  • Ipsen S.A.
  • Johnson & Johnson Services, Inc.
  • Koninklijke DSM N.V.
  • Lonza Group Ltd.
  • Lupin Limited
  • Mankind Pharma
  • MusclePharm Corporation
  • Mylan Pharmaceuticals Pvt. Ltd. by Viatris
  • Nature's Bounty, Inc. by Nestlé S.A.
  • Novartis AG
  • Omega Protein Corporation
  • Pfizer Inc.
  • Piramal Group
  • Procter & Gamble Company
  • PureTek Corporation
  • QuestNutrition
  • Reckitt Benckiser Group PLC
  • Sanofi S.A.
  • Sun Pharmaceutical Industries Limited
  • Takeda Pharmaceutical Company Limited
  • Teva Pharmaceutical Industries Ltd.
  • Ventus Pharmaceuticals Private Limited
  • Zoic Biotech Private Limited

Methodology

Loading
LOADING...

Table Information